Author:
Lux Janine,Sánchez García Lucía,Chaparro Fernández Patricia,Laloli Laura,Licheri Manon F.,Gallay Clement,Hermans Peter W. M.,Croucher Nicholas J.,Veening Jan-Willem,Dijkman Ronald,Straume Daniel,Hathaway Lucy J.
Abstract
AbstractKlebsiella pneumoniae releases the peptides AKTIKITQTR and FNEMQPIVDRQ, which bind the pneumococcal proteins AmiA and AliA respectively, two substrate-binding proteins of the ABC transporter Ami-AliA/AliB oligopeptide permease. Exposure to these peptides alters pneumococcal phenotypes such as growth. Using a mutant in which a permease domain of the transporter was disrupted, by growth analysis and epifluorescence microscopy, we confirmed peptide uptake via the Ami permease and intracellular location in the pneumococcus. By RNA-sequencing we found that the peptides modulated expression of genes involved in metabolism, as pathways affected were mostly associated with energy or synthesis and transport of amino acids. Both peptides downregulated expression of genes involved in branched-chain amino acid metabolism and the Ami permease; and upregulated fatty acid biosynthesis genes but differed in their regulation of genes involved in purine and pyrimidine biosynthesis. The transcriptomic changes are consistent with growth suppression by peptide treatment. The peptides inhibited growth of pneumococcal isolates of serotypes 3, 8, 9N, 12F and 19A, currently prevalent in Switzerland, and caused no detectable toxic effect to primary human airway epithelial cells. We conclude that pneumococci take up K. pneumoniae peptides from the environment via binding and transport through the Ami permease. This changes gene expression resulting in altered phenotypes, particularly reduced growth.
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Asokan, G. V., Ramadhan, T., Ahmed, E. & Sanad, H. WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain. Oman Med. J. 34, 184–193. https://doi.org/10.5001/omj.2019.37 (2019).
2. van der Poll, T. & Opal, S. M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543–1556. https://doi.org/10.1016/S0140-6736(09)61114-4 (2009).
3. Cillóniz, C., Garcia-Vidal, C., Ceccato, A. & Torres, A. Antimicrobial Resistance Among Streptococcus pneumoniae. In Antimicrobial Resistance in the 21st Century (eds Fong, I. et al.) (Springer, 2018).
4. Claverys, J. P., Grossiord, B. & Alloing, G. Is the Ami-AliA/B oligopeptide permease of Streptococcus pneumoniae involved in sensing environmental conditions?. Res. Microbiol. 151, 457–463. https://doi.org/10.1016/s0923-2508(00)00169-8 (2000).
5. Kerr, A. R. et al. The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect. Immun. 72, 3902–3906. https://doi.org/10.1128/iai.72.7.3902-3906.2004 (2004).